March 2024 Price Concessions 1st Update

THIS CONTENT HAS NOW EXPIRED

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (15/03/2024) announced the following initial list of price concessions for March 2024:

Drug  Pack size Price concession
Amiodarone 200mg tablets 28 £1.83
Aripiprazole 10mg tablets 28 £7.89
Aripiprazole 15mg tablets 28 £8.47
Baclofen 5mg/5ml oral solution sugar free 300 £3.64
Betamethasone valerate 0.1% cream 30 £1.43
Betamethasone valerate 0.1% cream 100 £4.99
Bimatoprost 100micrograms/ml eye drops 3 £4.46
Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops 3 £8.79
Bumetanide 1mg tablets 28 £2.35
Cefalexin 250mg capsules 28 £2.06
Co-careldopa 12.5mg/50mg tablets 90 £4.25
Co-codamol 15mg/500mg tablets 100 £3.25
Dexamfetamine 5mg tablets 28 £22.83
Digoxin 125microgram tablets 28 £2.75
Digoxin 250microgram tablets 28 £2.75
Digoxin 62.5microgram tablets 28 £2.75
Docusate 50mg/5ml oral solution sugar free 300 £17.79
Donepezil 5mg tablets 28 £1.50
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free 60 £25.03
Duloxetine 20mg gastro-resistant capsules 28 £8.88
Duloxetine 40mg gastro-resistant capsules 56 £11.25
Escitalopram 10mg tablets 28 £1.27
Estradiol 10microgram pessaries 24 £10.75
Ezetimibe 10mg tablets 28 £12.86
Haloperidol 1.5mg tablets 28 £3.66
Hydrocortisone 2.5% cream 15 £47.25
Irbesartan 300mg tablets 28 £1.35
Isotretinoin 20mg capsules 30 £10.78
Lamotrigine 100mg tablets 56 £3.20
Lamotrigine 200mg tablets 56 £4.81
Lamotrigine 25mg tablets 56 £1.92
Lamotrigine 50mg tablets 56 £2.84
Lansoprazole 30mg gastro-resistant capsules 28 £1.30
Memantine 10mg tablets 28 £1.30
Memantine 10mg/ml oral solution sugar free 50 £45.45
Memantine 20mg tablets 28 £1.58
Metformin 1g modified-release tablets 56 £2.71
Metformin 500mg modified-release tablets 56 £1.83
Metoprolol 50mg tablets 28 £3.75
Midazolam 10mg/2ml solution for injection ampoules 10 £5.39
Mometasone 50micrograms/dose nasal spray 140 £9.20
Montelukast 10mg tablets 28 £2.05
Montelukast 5mg chewable tablets sugar free 28 £1.21
Morphine sulfate 10mg/5ml oral solution 300 £5.45
Orlistat 120mg capsules 84 £23.35
Pregabalin 150mg capsules 56 £2.25
Primidone 250mg tablets 100 £86.95
Risperidone 1mg/ml oral solution sugar free 100 £3.13
Risperidone 2mg tablets 60 £1.99
Ropinirole 500microgram tablets 28 £15.75
Simvastatin 20mg tablets 28 £1.10
Simvastatin 80mg tablets 28 £1.61
Terbinafine 1% cream 15 £3.51
Terbinafine 1% cream 30 £7.02
Trazodone 150mg tablets 28 £2.14
Trospium chloride 20mg tablets 60 £11.36
Zolmitriptan 2.5mg tablets 6 £16.45
Zolmitriptan 2.5mg tablets 12 £32.90
Zonisamide 50mg capsules 56 £16.73

Please note: We are still in discussion with DHSC on a number other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department.

No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.

We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.

Please  subscribe to our mailing list to receive email updates of any price concessions.

Further information on price  concessions and FAQs about the process  involved  can be found on our website (cpe.org.uk/priceconcessions) To hear more on how the current price  concessions system operates, pharmacy teams can now access a recording of our recent Medicines Supply and Concessions Briefing webinar  here.

Improvements to the price concession system

Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by  DHSC  in second half of 2022, it was agreed that an  urgent review of the price concession setting system would take place.

Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.

One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.

In May 2023, DHSC implemented a process to roll over to the following month any agreed prices for concessions requested on or after the 23rd of the month.

Furthermore, from April 2024, a new retrospective top-up payment system will apply to products granted very low concessionary prices by DHSC when compared to the average purchase prices identified via the Margins survey. Further information on the top-up mechanism can be found here.

Our CEO gives a video update addressing the prolonged pause in the 2024/25 CPCF negotiations.

Click Here